Cargando…

Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases

• We report four non-hospitalized COVID-19 patients who developed VTE in their course of illness. • None of our patients had major risk factors for developing VTE. • A secondary respiratory worsening of COVID-19 should prompt investigation for the occurrence of VTE. • The use of thromboprohylaxis sh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Overstad, Siri, Tjonnfjord, Eirik, Garabet, Lamya, Fronas, Synne, Bergan, Jonas, Aballi, Saad, Ghanima, Waleed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Letter to the Editors-in-Chief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303641/ https://www.ncbi.nlm.nih.gov/pubmed/32788102 http://dx.doi.org/10.1016/j.thromres.2020.06.032

Ejemplares similares

PB2608: THE MANAGEMENT OF IMMUNE THROMBOCYTOPENIA (ITP) IN NORWAY IN THE REAL LIFE – ANALYSIS OF THE NOR-ITP REGISTRY
por: Ilicheva, Ekaterina, et al.
Publicado: (2023)

Managing suspected venous thromboembolism when a pandemic limits diagnostic testing
por: Schaefer, Jordan K., et al.
Publicado: (2020)

Arterial and venous thromboembolic disease in a patient with COVID-19: A case report
por: Brüggemann, Renée, et al.
Publicado: (2020)

Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis
por: Kunutsor, Setor K., et al.
Publicado: (2020)

Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors()
por: Nauka, Peter C., et al.
Publicado: (2021)

Bacterial surinfection and venous thromboembolism in critically ill ICU patients with COVID-19: What is the relationship?
por: Stessel, Björn, et al.
Publicado: (2021)

Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?
por: Zuin, Marco, et al.
Publicado: (2021)

Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19
por: Zermatten, Maxime G., et al.
Publicado: (2020)

D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19
por: Choi, Justin J., et al.
Publicado: (2020)

No evidence of increased rate of thrombotic recurrences in patients with history of venous thromboembolism after vaccination for COVID-19
por: Porfidia, Angelo, et al.
Publicado: (2022)

Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: A systematic review and meta-analysis
por: Zuin, Marco, et al.
Publicado: (2022)

Thromboembolic complications during and after hospitalization for COVID-19: Incidence, risk factors and thromboprophylaxis
por: Tholin, Birgitte, et al.
Publicado: (2022)

In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis
por: Mumoli, Nicola, et al.
Publicado: (2021)

COVID-19 associated Venous Thromboembolism (VTE) burden in Black women: Findings of Veterans Affairs COVID-19 Shared Data
por: Choi, Sung-Hee, et al.
Publicado: (2022)

Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019
por: Hightower, Stephanie, et al.
Publicado: (2020)

Updated hospital associated venous thromboembolism outcomes with 90-days follow-up after hospitalisation for severe COVID-19 in two UK critical care units
por: Doyle, Andrew J., et al.
Publicado: (2020)

The venous thrombosis registry in Østfold Hospital (TROLL registry) ‐ design and cohort description
por: Jørgensen, Camilla Tøvik, et al.
Publicado: (2022)

P1697: EVALUATION OF THE DIAGNOSTIC PERFORMANCE OF THE TINA-QUANT D-DIMER GEN. 2 IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS
por: Tonne, B., et al.
Publicado: (2022)

Major cardiovascular events in patients with Coronavirus Disease 2019: Experience of a cardiovascular department of Northern Italy()
por: Bellosta, Raffaello, et al.
Publicado: (2021)

Early thromboembolic events in hospitalized COVID-19 patients
por: Rosen, Raphael J.
Publicado: (2020)

Coronavirus disease 2019 is associated with catheter-related thrombosis in critically ill patients: A multicenter case-control study
por: Smit, Jasper M., et al.
Publicado: (2021)

Prevention of venous thromboembolism in ambulatory patients with cancer
por: Khorana, Alok A, et al.
Publicado: (2020)

Thromboembolic events related to atrial fibrillation during the COVID-19 epidemic in Denmark
por: Rasmussen, Peter Vibe, et al.
Publicado: (2020)

Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era
por: Qin, Wei, et al.
Publicado: (2021)

The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome?
por: Previtali, Giulia, et al.
Publicado: (2020)

Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia
por: Beenen, L.F.M., et al.
Publicado: (2020)

Fatigue after initiating rivaroxaban for venous thromboembolism
por: Karlsvik, Tina Margrethe, et al.
Publicado: (2020)

Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination
por: Franchini, Massimo, et al.
Publicado: (2021)

Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019
por: Thondapu, Vikas, et al.
Publicado: (2021)

Safety of COVID-19 vaccination in patients with previous cerebral venous sinus thrombosis
por: Gil-Díaz, Aída, et al.
Publicado: (2022)

Malnutrition and Venous Thromboembolism are Specific Issues in Elderly Patients with Coronavirus Disease 2019
por: Qin, Zheng, et al.
Publicado: (2021)

Venous thromboembolism in hospitalized coronavirus disease 2019 patients stratified by vaccination status
por: Bozzani, Antonio, et al.
Publicado: (2023)

Role of Fibrin Monomer Complex in Coronavirus Disease 2019 for Venous Thromboembolism and the Prognosis
por: Kawame, Chiaki, et al.
Publicado: (2023)

The Coronavirus Disease 2019 Likelihood of Thrombosis Calculator: Predicting Venous Thromboembolism Risk in Hospitalized Patients With Coronavirus Disease 2019
por: Meena, Richard A., et al.
Publicado: (2021)

Convalescent plasma therapy for coronavirus disease 2019 in ambulatory versus hospitalized patients: Efficacy and risk of thromboembolism
por: Li, Pei Ye, et al.
Publicado: (2023)

Preventing Venous Thromboembolism in Ambulatory Patients with Cancer: A Narrative Review
por: Rossel, Anne, et al.
Publicado: (2020)

Updated meta-analysis on prevention of venous thromboembolism in ambulatory cancer patients
por: Becattini, Cecilia, et al.
Publicado: (2020)

The effect of anticoagulation on clinical outcomes in novel Coronavirus (COVID-19) pneumonia in a U.S. cohort
por: Lynn, Lei, et al.
Publicado: (2021)

Three cases of acute venous thromboembolism in females after vaccination for coronavirus disease 2019
por: Andraska, Elizabeth A., et al.
Publicado: (2022)

Comparison of IMPROVE, modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC risk scores for venous and arterial thrombotic events prediction in hospitalized COVID-19 patients
por: Lucijanic, Marko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sauoilq1i6abkiisve1pv75tkh